Co-Delivery Nanomicelles for Potentiating TNBC Immunotherapy by Synergetically Reshaping CAFs-Mediated Tumor Stroma and Reprogramming Immunosuppressive Microenvironment

PURPOSE: Immune checkpoint inhibitors (ICI) have received the most attention for triple negative breast cancer (TNBC), while the response rate to ICI remains limited due to insufficient T cell infiltration. It is therefore essential that alternative strategies are developed to improve the therapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yue, Han, Xue, Wang, Ke, Liu, Da, Ding, Xiaoyun, Hu, Zhiqiang, Wang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403052/
https://www.ncbi.nlm.nih.gov/pubmed/37545872
http://dx.doi.org/10.2147/IJN.S418100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403052/
https://www.ncbi.nlm.nih.gov/pubmed/37545872
http://dx.doi.org/10.2147/IJN.S418100

Ejemplares similares